Cipla board approves appointment of Dr Reddy’s Laboratories’ Kedar Upadhye as Global CFO

By: |
New Delhi | June 08, 2016 5:14 PM

Drug firm Cipla today said its board has approved appointment of Kedar Upadhye as the company's Global Chief Financial Officer.

The board of directors today "approved the appointment of Kedar Upadhye as Global Chief Financial Officer of the company who will assume office on or before August 16, 2016," Cipla said in a filing to BSE.The board of directors today “approved the appointment of Kedar Upadhye as Global Chief Financial Officer of the company who will assume office on or before August 16, 2016,” Cipla said in a filing to BSE.

Drug firm Cipla today said its board has approved appointment of Kedar Upadhye as the company’s Global Chief Financial Officer.

The board of directors today “approved the appointment of Kedar Upadhye as Global Chief Financial Officer of the company who will assume office on or before August 16, 2016,” Cipla said in a filing to BSE.

Upadhye will replace Umang Vohra, who will continue to be the Global Chief Operating Officer, it added.

At present, Upadhye is with Dr Reddy’s Laboratories where he is Vice President, Global Generics Finance and Head  of Investor Relations, Cipla said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
18 crore retail, wholesale traders incur Rs 6.25 lakh cr business loss due to Covid restrictions
2Coal India to continue with fuel supply to power plants under import substitution in current fiscal
3Will double headcount; lot of headroom for growing user base: Koo